MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Design Standards as Strategic Assets
Done correctly, standards benefit healthcare environments, staff, patients and families.
Rising Violence is Exposing Gaps in Hospital Security
Security experts outline how healthcare facilities can move beyond traditional security to more proactive and coordinated systems.
Murray County Medical Center Reports Data Security Incident
MCMC has implemented several measures to enhance its security posture and reduce the risk of similar future incidents.
Probiotic Cleaning: A Complementary Strategy for Safer Hospital Floors
Managers seeking more resilient approaches to environmental hygiene are turning to probiotic systems to supplement traditional disinfection.
VITAS Healthcare Breaks Ground on New Inpatient Hospice Center in Florida
The 14,000-square-foot VITAS inpatient hospice center will open in 2027 and serve 500+ patients annually.